Our pilot study revealed, for the first time, that PB neutrophils from LR-MDS not only frequently have decreased FSC and/or SSC, but also commonly display abnormally low levels of CD11b, CD11c, CD10, CD16, CD13 and CD45 expression, as compared to normal neutrophils. Here, ITGAX is linked to myelodysplastic syndrome.